Daniel Luu, PharmD, MS

Article

Evaluating Sorafenib in Veterans With Advanced Hepatocellular Carcinoma

Author:

Daniel Luu, PharmD, MS

Sorafenib remains a viable therapeutic option for patients with advanced hepatocellular carcinoma but may present some risks for a veteran populati...

• Read More